Stiris Research’s CEO Ranks No. 9 on the W100
PROFIT and Canadian Business today ranked Shantal Feltham, President and CEO of Stiris Research Inc., No. 9 on the 18th annual W100 list of Canada’s Top Female Entrepreneurs. Published today at PROFITguide.com, the W100 ranks female entrepreneurs using a proprietary formula that considers the size, growth rate and profitability of the businesses they own and manage.
“The members of the 2016 W100 each possess the talent and tenacity to start and grow a successful business,” said James Cowan, Editor-in-chief of PROFIT and Canadian Business. “Their remarkable achievements serve as proof that ambitious, risk-taking female entrepreneurs are integral to the growth of the Canadian economy.”
“Stiris Research is honored to be on the W100 ranking,” says President and CEO Shantal Feltham. “This achievement reflects the continued strength of our business and the dedication of our entire team.”
ABOUT THE W100
Now in its 18th year, the W100 ranking of Canada’s Top Female Entrepreneurs is Canada’s largest celebration of achievement by women business owners. Produced by the editors of PROFIT and Canadian Business, the rankings and extended coverage of the women honoured are published in print and online. Applicants to the 2016 W100 were ranked using a proprietary formula that considers the size, growth rate and profitability of the companies they own and manage. To see this year’s complete ranking and find links to full W100 editorial coverage, visit PROFITguide.com.
STIRIS RESEARCH INC.
Stiris Research is making a difference by collaborating for successful drug approvals.
Stiris Research is an entrepreneurial Clinical Trial Management Company providing clinical study management solutions to biotechnology companies for the execution of complex Phase I-IIIB clinical trials. We work with our clients to provide customized solutions based on individual needs and resource requirements.
In addition to placing 9th on the 2016 W100 list of Canada’s Top Female Entrepreneurs, Stiris Research is also the recipient of the PROFIT HOT 50 award, a ranking of Canada’s most promising businesses, the PROFIT 500 award, the definitive ranking of Canada’s Fastest-Growing Companies and the 2011 London Chamber of Commerce Small Business of the Year award.
About Stiris Research
Stiris Research is an entrepreneurial Clinical Trial Management company specializing in conducting complex Phase I through IIIB trials for North American biotechnology and biopharmaceutical companies, with a focus on Oncology, CNS and Neurology. Stiris Research was formed as a result of listening to the stakeholders engaged in clinical trials, identifying their unmet needs, and developing a unique, value-based approach to address those needs.
For more information, please contact: